Fulvestrant, an estrogen receptor antagonist, blocks proliferation and differentiation of cultured primary human osteoblasts

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Original languageEnglish
Title of host publicationBone
PagesS463-4
Number of pages2
Volume36
Publication statusPublished - 2005

Cite this